Intestinal Failure Clinical Trial
Official title:
Effect of Vitamin D Supplementation on Skeletal Muscle Function and Quality of Life in Patients With Chronic Intestinal Failure/Insufficiency: A Randomised Clinical Trial
Eligible patients were randomized into two groups: Vitamin D group and Control group. Control group: routine treatment only, no additional vitamin D intervention therapy. Vitamin D group: In addition to the conventional treatment, additional intramuscular injection of vitamin D2 was given once every two weeks, each dose of 600,000 units, and the treatment lasted for 12 weeks. The primary and secondary outcomes will be collected.
Eligible patients with chronic intestinal failure/insufficiency were randomly assigned to one of two groups, Vitamin D group and Control group. Control group: routine treatment only, no additional vitamin D intervention therapy. Vitamin D group: In addition to the conventional treatment, additional intramuscular injection of vitamin D2 was given once every two weeks, each dose of 600,000 units, and the treatment lasted for 12 weeks. The primary and secondary outcomes will be collected. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04733066 -
Quality of Life in Patients With Short Bowel Syndrome Treated Without and With Teduglutide - a Prospective Nested Matched Pair Analysis
|
||
Recruiting |
NCT05315765 -
Development of a Patient Reported Outcome Measure for GastroIntestinal Recovery
|
||
Recruiting |
NCT04577456 -
Chyme Reinfusion for Type 2 Intestinal Failure
|
N/A | |
Recruiting |
NCT03590418 -
Microbial Diversity of Small Bowel Stoma Effluent and Colonic Faeces
|
||
Completed |
NCT05909228 -
Bone Markers in Pediatric IF
|
||
Enrolling by invitation |
NCT06094504 -
Spectral Lighting and Intestinal Failure
|
N/A | |
Recruiting |
NCT05902104 -
CGM-Assisted Management of PN
|
||
Completed |
NCT01386034 -
Effects of Oral Citrulline on Protein Metabolism in Patients With Intestinal Failure (Citrugrêle 2)
|
Phase 3 | |
Recruiting |
NCT05868785 -
Effect of Nocturnal Parenteral Nutrition on Bone Turnover and Energy Metabolism
|
N/A | |
Terminated |
NCT01573286 -
Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT00793195 -
Can SMOFlipid®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition Associated Liver Disease In Infants?
|
Phase 2 | |
Recruiting |
NCT06169774 -
Video Training Supplementation for Patients Discharged on Home Parental Nutrition
|
N/A | |
Completed |
NCT03222232 -
Catheter Salvage in Intestinal Failure Patients
|
N/A | |
Completed |
NCT06391762 -
Level of Deprivation Assessment in a Population of Short-bowel Syndrome Patients With Intestinal Failure
|
||
Completed |
NCT01986153 -
Essential Fatty Acid Status & Immune Function in Parenteral Nutrition Patients
|
N/A | |
Completed |
NCT00995813 -
Pilot Study of the Rotavirus Vaccine in Infants With Intestinal Failure
|
Phase 4 | |
Recruiting |
NCT05813535 -
8.4% Sodium Bicarbonate Locks in Intestinal Failure
|
Phase 2 | |
Completed |
NCT03869957 -
Effect of Parenteral Nutrition With n-3 PUFAs on Patients With Intestinal Failure
|
N/A | |
Completed |
NCT00286039 -
Plasma Citrulline Level in Relation to Absorptive Surface
|
N/A | |
Completed |
NCT01946503 -
Infant & Toddler Short Gut Feeding Outcomes Study
|